Select Medical Holdings Corporation reported that Glazer Capital, LLC and Paul J. Glazer beneficially own 6,465,826 shares of Common Stock, representing 5.21% of the class as of 05/07/2026. The filing states Glazer Capital and Mr. Glazer share voting and dispositive power over these shares.
The statement clarifies the holdings are reported by the investment manager and its managing member and includes the reporting persons' business address in New York. The filing does not assert additional transactions or changes beyond the ownership disclosure.
Positive
None.
Negative
None.
Insights
Glazer Funds report a 5.21% passive stake in Select Medical.
The filing lists 6,465,826 shares and a 5.21% class stake as of 05/07/2026, with shared voting and dispositive power. This is a Schedule 13G-style disclosure reflecting ownership by an investment manager and its managing member.
Impact depends on whether the position is passive under Schedule 13G terms; subsequent filings could change characterization. Future filings may disclose changes in voting arrangements or ownership level.
Shared voting/dispositive power is reported, not sole control.
The statement specifies 0 sole voting power and 6,465,826 shared voting and dispositive power, indicating joint control within the Glazer reporting group. The filing includes the reporting persons' address and signatures dated 05/14/2026.
Any governance influence depends on coordination among holders with shared power; the filing itself does not describe agreements or plans to act in concert beyond the reporting-group disclosure.
Key Figures
Shares beneficially owned:6,465,826 sharesPercent of class:5.21%Sole voting power:0+3 more
6 metrics
Shares beneficially owned6,465,826 sharesAmount reported in Item 4(a)
Percent of class5.21%Percent of class reported in Item 4(b)
Sole voting power0Item 4(c)(i) lists sole voting power
Shared voting power6,465,826 sharesItem 4(c)(ii) lists shared voting power
Report date05/07/2026Date shown near CUSIP/header
Signature date05/14/2026Signatures dated in filing footer
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Schedule 13Gregulatory
"This statement is filed by: (i) Glazer Capital, LLC"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
What stake does Glazer Capital report in Select Medical (SEM)?
Glazer Capital and Paul J. Glazer report beneficial ownership of 6,465,826 shares, equal to 5.21% of common stock as of 05/07/2026. The filing attributes shared voting and shared dispositive power to the reporting persons.
Does the Schedule 13G filing show who controls the shares?
The filing states 0 sole voting power and 6,465,826 shared voting and dispositive power, indicating the shares are reported under shared control by Glazer Capital and Mr. Glazer rather than sole control.
When was this ownership position reported for SEM?
The filing lists an ownership date of 05/07/2026 and signatures dated 05/14/2026. The ownership figures in the statement are tied to the 05/07/2026 reporting date.
Is this Schedule 13G an indication of an activist intent?
The filing reports an ownership stake of 5.21% under an investment manager and managing member. It does not state activist intent, voting agreements, or plans to influence management in the provided excerpt.
Where is the reporting person's business address listed?
The business office for Glazer Capital and Paul J. Glazer is listed as 250 West 55th Street, Suite 30A, New York, New York 10019 in the filing's Item 2(b).
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
SELECT MEDICAL HOLDINGS CORPORATION
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
81619Q105
(CUSIP Number)
05/07/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
81619Q105
1
Names of Reporting Persons
Glazer Capital, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,465,826.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,465,826.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,465,826.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.21 %
12
Type of Reporting Person (See Instructions)
IA, OO
SCHEDULE 13G
CUSIP Number(s):
81619Q105
1
Names of Reporting Persons
Paul J. Glazer
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,465,826.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,465,826.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,465,826.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.21 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
SELECT MEDICAL HOLDINGS CORPORATION
(b)
Address of issuer's principal executive offices:
4714 Gettysburg Road, P.O. Box 2034 Mechanicsburg, PA 17055
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Glazer Capital, LLC, a Delaware limited liability company ("Glazer Capital"), with respect to the shares of Common Stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Glazer Capital serves as investment manager (collectively, the "Glazer Funds"); and
(ii) Mr. Paul J. Glazer ("Mr. Glazer"), who serves as the Managing Member of Glazer Capital, with respect to the shares of Common Stock held by the Glazer Funds.
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock (as defined in Item 2(d)) reported herein.
(b)
Address or principal business office or, if none, residence:
The address of the business office of each of the Reporting Persons is 250 West 55th Street, Suite 30A, New York, New York 10019.
(c)
Citizenship:
Glazer Capital is a Delaware limited liability company. Mr. Glazer is a United States citizen.
(d)
Title of class of securities:
Common Stock, par value $0.001 per share
(e)
CUSIP Number(s):
81619Q105
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
6,465,826
(b)
Percent of class:
5.21%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
6,465,826
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
6,465,826
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 2.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
